Novel Glycoproteomic based diagnostic technology for identifying cartilage tissue turnover and repair. Osteoarthritis is a long-term debilitating disease, which results in the loss of cartilage in the joints, leading to pain and disability. This is a major problem and cost in ageing societies, yet the mechanisms of joint deterioration are still poorly understood. This project will investigate proteoglycans and proteoglycan fragments produced by cells of the joint, detailing the structure of th ....Novel Glycoproteomic based diagnostic technology for identifying cartilage tissue turnover and repair. Osteoarthritis is a long-term debilitating disease, which results in the loss of cartilage in the joints, leading to pain and disability. This is a major problem and cost in ageing societies, yet the mechanisms of joint deterioration are still poorly understood. This project will investigate proteoglycans and proteoglycan fragments produced by cells of the joint, detailing the structure of their sugar components, and map which regions are interacting with antibodies. Understanding these proteoglycan fragments will help us to determine their role in disease progression, and application of this knowledge will assist in the development of an early diagnostic for osteoarthritis.Read moreRead less
Material structure and properties of mineralised tissue: An integrated micro and nano level investigation. Bone material properties have a direct influence on disorders of the skeleton, such as osteoporotic bone fragility fractures and osteoarthritis. It has been estimated that the direct and indirect cost of all fragility fractures and arthritis is over $20 billion per annum. The impact of this will be far-reaching with the social benefits ranging from earlier and more accurate diagnoses, to t ....Material structure and properties of mineralised tissue: An integrated micro and nano level investigation. Bone material properties have a direct influence on disorders of the skeleton, such as osteoporotic bone fragility fractures and osteoarthritis. It has been estimated that the direct and indirect cost of all fragility fractures and arthritis is over $20 billion per annum. The impact of this will be far-reaching with the social benefits ranging from earlier and more accurate diagnoses, to the development of preventative strategies to delay the onset of musculoskeletal disorders. These developments will translate into exciting commercial opportunities and overall economic growth and sustainability.Read moreRead less